The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease
Study Details
Study Description
Brief Summary
The rapid spread of COVID-19 is expected to have a significant impact on medicine as well as all sectors worldwide. In particular, inflammatory bowel disease (IBD) is a chronic immune disease in which remission and activation are repeated and must be treated consistently throughout life. In addition, patients with IBD may be vulnerable to various infectious diseases due to the immuno-compromised state due to the use of immuno-suppressants or biological agents. During a pandemic, patients with IBD may postpone hospital visits due to concerns about infection with COVID-19, and if they cannot continue drug treatment, there is a concern about the flare up IBD disease activity. Therefore, in this study, we would like to investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital ultilization.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Background: In the epidemic area of COVID-19, emergency treatment of chronic diseases other than COVID-19 can be limited. Therefore, it is important to reduce the risk of exposure to COVID-19 in patients with chronic immune diseases such as IBD, but it is most important to manage well so that the underlying diseases are not exacerbated at times when emergency medical treatment may be difficult. However, there is a lack of evidence on the management policy of chronic immune diseases in the current epidemic, and only expert opinions are being presented.
Aim: To investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital utilization.
Material and method: This study is a multicenter, prospective, cross-sectional survey which will be consulted in Keimyung University Dongsan Medical Center and Yeungnam University Hospital. Patients with IBD aged above 18 will enrolled and surveyed about their perception about COVID-19 and status of hospital utilization during pandemic period. Patients' demographics and disease-related variables will be evaluated to identify clinical significances.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Inflammatory bowel disease Patients with inflammatory bowel disease who live in COVID-19 hyperemic area |
Other: Interview
Surveys on medical use patterns and patient's perceptions about COVID-19
|
Outcome Measures
Primary Outcome Measures
- Patient's perception of COVID-19 and medical use patterns [1day]
Correlation between patient's perception of COVID-19 and medical use patterns during the pandemic period
Secondary Outcome Measures
- Exacerbation of symptoms [1day]
Exacerbation of symptoms in patients with IBD during the pandemic period
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients with inflammatory growth disease, those who agreed to participate in this study
Exclusion Criteria:
-
Those who are unable to understand or answer the questionnaire
-
Those who declined to participate in this study
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | KeimyungUniversity | Daegu | Jung-gu | Korea, Republic of | 700-712 |
Sponsors and Collaborators
- Keimyung University Dongsan Medical Center
- Yeungnam University College of Medicine
Investigators
- Principal Investigator: Yoojin Lee, M.D., Keimyung University Dongsan Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2020-04-070